Renal dysfunction in allogeneic hematopoietic cell transplantationPARIKH, Chirag R; MCSWEENEY, Peter A; SCHRIER, Robert W et al.Kidney international. 2002, Vol 62, Num 2, pp 566-573, issn 0085-2538Article

Intensive dose-dense compared with high-dose adjuvant chemotherapy for high-risk operable breast cancer : Southwest oncology group/intergroup study 9623MOORE, Halle C. F; GREEN, Stephanie J; ELIAS, Anthony D et al.Journal of clinical oncology. 2007, Vol 25, Num 13, pp 1677-1682, issn 0732-183X, 6 p.Article

Prognostic model for relapse after high-dose chemotherapy with autologous stem-cell transplantation for stage IV oligometastatic breast cancerNIETO, Yago; NAWAZ, Samia; JONES, Roy B et al.Journal of clinical oncology. 2002, Vol 20, Num 3, pp 707-718, issn 0732-183XArticle

Phase II feasibility and pharmacokinetic study of concurrent administration of trastuzumab and high-dose chemotherapy in advanced HER2+ breast cancerNIETO, Yago; VREDENBURGH, James J; JONES, Roy B et al.Clinical cancer research. 2004, Vol 10, Num 21, pp 7136-7143, issn 1078-0432, 8 p.Article

Dose-intense chemotherapy every 2 weeks with dose-intense cyclophosphamide, doxorubicin, vincristine, and prednisone may improve survival in intermediate- and high-grade lymphoma: A phase II study of the Southwest Oncology group (SWOG 9349)BLAYNEY, Douglas W; LEBLANC, Michael L; GROGAN, Thomas et al.Journal of clinical oncology. 2003, Vol 21, Num 13, pp 2466-2473, issn 0732-183X, 8 p.Article